Co-financed by:

Designation of the project | HighSenseCoV2 Highly sensitive immunoassay for SARS-CoV2 detection using new amplification technology.

Project code | LISBOA-01-02B7-FEDER-069951; NORTE-01-02B7-FEDER-069951

Main Goal | Reinforce research, technologic development and innovation

Region of Intervention | Lisbon; North

Beneficiary Entities | ABDART DIAGNOSTICS (Leader); INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES; LABORATÓRIO IBÉRICO INTERNACIONAL DE NANOTECNOLOGIA; INOVA+

Date of approval | 2020-12-14

Date of beginning | 2020-12-01
Date of conclusion | 2021-08-26

Total eligible amount | 477.702,42 EUR

Financial support from European Union | FEDER – 399.324,82 EUR

HighSenseCoV2 is a project aiming to use our DART amplification technology with current immunologic assay technologies, in order to improve testing devices, namely LFT (lateral flow tests). This is expected to increase the sensibility of the detection system, contributing for an efficient and faster detection of people exposed to the virus.